IMCIVREE

Serial Number 88226182
Registration 6364874
700

Registration Progress

Application Filed
Dec 12, 2018
Under Examination
Jul 9, 2019
Approved for Publication
May 14, 2019
Published for Opposition
May 14, 2019
Registered
May 25, 2021

Trademark Image

IMCIVREE

Basic Information

Serial Number
88226182
Registration Number
6364874
Filing Date
December 12, 2018
Registration Date
May 25, 2021
Published for Opposition
May 14, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 25, 2021
Registration
Registered
Classes
005

Rights Holder

Rhythm Pharmaceuticals, Inc.

03
Address
222 Berkeley Street, Suite 1200
BOSTON, MA 02116

Ownership History

Rhythm Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Rhythm Pharmaceuticals, Inc.

Owner at Publication
03
BOSTON, MA

Rhythm Pharmaceuticals, Inc.

Original Registrant
03
BOSTON, MA

Legal Representation

Attorney
Peter G. Byrne, Esq.

USPTO Deadlines

Next Deadline
658 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-25)
Due Date
May 25, 2027
Grace Period Ends
November 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Jun 20, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 20, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 20, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 20, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 16, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 16, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 16, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 25, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 23, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 22, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 13, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 12, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 25, 2021 IUAF S USE AMENDMENT FILED Loading...
Mar 25, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 5, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 31, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 31, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 31, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 1, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 16, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 16, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 16, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 14, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 14, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 24, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 12, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 12, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 12, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 12, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 12, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 11, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 15, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders
First Use Anywhere: Mar 1, 2021
First Use in Commerce: Mar 1, 2021

Classification

International Classes
005